Related Experiment Video
Updated: Aug 8, 2026

07:17
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
[Vitaprost efficacy in patients with chronic abacterial prostatitis]
Urologiia (Moscow, Russia : 1999)
|May 20, 2006
Summary
Vitaprost effectively treats chronic abacterial prostatitis by improving symptoms, prostate blood flow, and sperm motility. This cytomedine drug offers a new therapeutic option for patients.
Area of Science:
- Urology
- Pharmacology
- Immunology
Context:
- Chronic abacterial prostatitis affects numerous patients, presenting complex symptoms and impacting quality of life.
- Current treatment options for chronic abacterial prostatitis have limitations, necessitating novel therapeutic approaches.
Purpose:
- To evaluate the efficacy of a new cytomedine drug, Vitaprost, in patients diagnosed with chronic abacterial prostatitis.
Summary:
- Vitaprost demonstrated significant improvements in symptom relief for 98 patients with chronic abacterial prostatitis.
- The study observed enhanced prostatic blood flow, normalized blood rheology, and improved immunological markers following Vitaprost administration.
- Vitaprost treatment led to increased sperm mobility in the ejaculate of the studied patients.
Impact:
- Vitaprost shows promise as an effective therapeutic agent for managing chronic abacterial prostatitis.
- This research contributes to understanding the pharmacological effects of cytomedine drugs on prostate health and male reproductive function.
